Skip to Content

W 923 (ENALAPRIL 2.5 mg)

Pill imprint W 923 has been identified as Enalapril maleate 2.5 mg.

Enalapril is used in the treatment of high blood pressure; diabetic kidney disease; heart failure; hypertensive emergency; left ventricular dysfunction (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Enalapril 2.5 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Enalapril maleate 2.5 mg W 923  Front
Enalapril maleate 2.5 mg W 923  Back
Enalapril maleate 2.5 mg W 923
Enalapril maleate 2.5 mg W 923
Enalapril maleate
W 923
2.5 mg
6.00 mm
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Wockhardt USA
National Drug Code (NDC):
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00172-4195 Ivax Pharmaceuticals Inc
63304-0834 Ranbaxy Pharmaceuticals Inc.
00904-5609 Major Pharmaceuticals

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.